阿斯利康AstraZeneca plc (AZN) 2014年年度报告「LSE」.pdf

1、What science can doAstraZeneca Annual Report and Form 20-F Information 2014Welcome to the AstraZeneca Annual Report and Form 20-F Information 2014.At AstraZeneca,each and every one of us is bold in the belief that science should be at the centre of everything we do.Science compels us to push the bou

2、ndaries of what is possible.We trust in the potential of ideas and pursue them,alone and with others,until we have transformed the treatment of disease.AstraZeneca.What science can do.See what science can doThe future of treatment for many of todays diseases lies in uncovering mechanisms that are ne

3、wly emerging or arestill to be discovered.We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel,targeted therapies that interact with them.This is at the heart of our business and our purpose as a company:to push the boundaries of

4、 science to deliver life-changing medicines.make hearts healthierhelp people breathe easierhelp more people survive cancerImportant information for readers of this Annual Report For more information in relation to the inclusion of reported performance,Core financial measures and constant exchange ra

5、te(CER)growth rates as used in this Annual Report,please see the Financial Review on page 72.Throughout this Annual Report,growth rates are expressed at CER unless otherwise stated.Definitions The Glossary and the Market definitions table from page 239 are intended to provide a useful guide to terms

6、 and AstraZenecas definitions of markets,as well as to acronyms andabbreviations,used in this Annual Report.Use of terms In this Annual Report,unless the context otherwise requires,AstraZeneca,the Group,we,us and our refer to AstraZeneca PLC and its consolidated entities.Cautionary statement regardi